+--------------------------------------------------+-------------------+
| **[World Trade]{.smallcaps}**                    |                   |
|                                                  |                   |
| **[Organization]{.smallcaps}**                   |                   |
+--------------------------------------------------+-------------------+
|                                                  |                   |
+--------------------------------------------------+-------------------+
|                                                  | **                |
|                                                  | G/TBT/N/USA/180** |
|                                                  |                   |
|                                                  | 27 March 2006     |
+--------------------------------------------------+-------------------+
|                                                  | (06-1360)         |
+--------------------------------------------------+-------------------+
|                                                  |                   |
+--------------------------------------------------+-------------------+
| **Committee on Technical Barriers to Trade**     | Original: English |
+--------------------------------------------------+-------------------+

NOTIFICATION

The following notification is being circulated in accordance with
Article 10.6.

+---+----------------------------+---+---------------------------------+
| * | **Member to Agreement      |   |                                 |
| * | notifying:** [UNITED       |   |                                 |
| 1 | STATES]{.underline}        |   |                                 |
| . |                            |   |                                 |
| * | **If applicable, name of   |   |                                 |
| * | local government involved  |   |                                 |
|   | (Articles 3.2 and 7.2):**  |   |                                 |
|   |                            |   |                                 |
+---+----------------------------+---+---------------------------------+
| * | **Agency responsible:** :  |   |                                 |
| * | Food and Drug              |   |                                 |
| 2 | Administration (FDA) (186) |   |                                 |
| . |                            |   |                                 |
| * | **Name and address         |   |                                 |
| * | (including telephone and   |   |                                 |
|   | fax numbers, e-mail and    |   |                                 |
|   | web-site addresses, if     |   |                                 |
|   | available) of** **agency   |   |                                 |
|   | or authority designated to |   |                                 |
|   | handle comments regarding  |   |                                 |
|   | the notification shall be  |   |                                 |
|   | indicated if different     |   |                                 |
|   | from above:**              |   |                                 |
+---+----------------------------+---+---------------------------------+
| * | **Notified under Article   |   |                                 |
| * | 2.9.2 \[** X **\], 2.10.1  |   |                                 |
| 3 | \[ **  **\], 5.6.2         |   |                                 |
| . | \[ **  **\], 5.7.1         |   |                                 |
| * | \[ **  **\], other:**      |   |                                 |
| * |                            |   |                                 |
+---+----------------------------+---+---------------------------------+
| * | **Products covered (HS or  |   |                                 |
| * | CCCN where applicable,     |   |                                 |
| 4 | otherwise national tariff  |   |                                 |
| . | heading.\                  |   |                                 |
| * | ICS numbers may be         |   |                                 |
| * | provided in addition,      |   |                                 |
|   | where applicable):**       |   |                                 |
|   |                            |   |                                 |
|   | Contact lenses(HS: Chapter |   |                                 |
|   | 9001) (ICS: 11)            |   |                                 |
+---+----------------------------+---+---------------------------------+
| * | **Title, number of pages   |   |                                 |
| * | and language(s) of the     |   |                                 |
| 5 | notified document:** CIBA  |   |                                 |
| . | Vision Corp.; Filing of    |   |                                 |
| * | Color Additive Petitions;  |   |                                 |
| * | Notice (2 pages, English)  |   |                                 |
+---+----------------------------+---+---------------------------------+
| * | **Description of           |   |                                 |
| * | content:** FDA has         |   |                                 |
| 6 | announced that CIBA Vision |   |                                 |
| . | Corp. has filed three      |   |                                 |
| * | petitions proposing that   |   |                                 |
| * | the color additive         |   |                                 |
|   | regulations in 21 CFR part |   |                                 |
|   | 73 be amended to permit    |   |                                 |
|   | the use of C.I. Pigment    |   |                                 |
|   | Violet 19 (CAP 5C0278),    |   |                                 |
|   | C.I. Pigment Yellow 154    |   |                                 |
|   | (CAP 5C0279), and C.I.     |   |                                 |
|   | Pigment Red 122 (CAP       |   |                                 |
|   | 5C0280) as color additives |   |                                 |
|   | in contact lenses.         |   |                                 |
+---+----------------------------+---+---------------------------------+
| * | **Objective and rationale, |   |                                 |
| * | including the nature of    |   |                                 |
| 7 | urgent problems where      |   |                                 |
| . | applicable:** Protection   |   |                                 |
| * | of human health, product   |   |                                 |
| * | safety                     |   |                                 |
+---+----------------------------+---+---------------------------------+
| * | **Relevant documents:** .  |   |                                 |
| * | Will appear in the Federal |   |                                 |
| 8 | Register when adopted.     |   |                                 |
| . |                            |   |                                 |
| * |                            |   |                                 |
| * |                            |   |                                 |
+---+----------------------------+---+---------------------------------+
| * | **Proposed date of         |   | To be determined                |
| * | adoption:**                |   |                                 |
| 9 |                            |   |                                 |
| . | **Proposed date of entry   |   |                                 |
| * | into force:**              |   |                                 |
| * |                            |   |                                 |
+---+----------------------------+---+---------------------------------+
| * | **Final date for           |   |                                 |
| * | comments:** Comments will  |   |                                 |
| 1 | be accepted at anytime     |   |                                 |
| 0 | after publication of this  |   |                                 |
| . | notice of filing; however, |   |                                 |
| * | if a final rule is         |   |                                 |
| * | promulgated, it will       |   |                                 |
|   | address only those         |   |                                 |
|   | comments that were         |   |                                 |
|   | received prior to          |   |                                 |
|   | publication of the final   |   |                                 |
|   | rule.                      |   |                                 |
+---+----------------------------+---+---------------------------------+
| * | **Texts available from:    |   |                                 |
| * | National enquiry point     |   |                                 |
| 1 | \[** X **\] or address,    |   |                                 |
| 1 | telephone and fax numbers, |   |                                 |
| . | e-mail and web-site        |   |                                 |
| * | addresses, if available of |   |                                 |
| * | the other body:**          |   |                                 |
|   |                            |   |                                 |
|   | **Full Texts are Now       |   |                                 |
|   | Available on the Internet  |   |                                 |
|   | at URLs:**                 |   |                                 |
|   |                            |   |                                 |
|   | <http://www.fda.gov/ohrms/ |   |                                 |
|   | dockets/98fr/05-16332.pdf> |   |                                 |
+---+----------------------------+---+---------------------------------+